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A BST R AC T   
 
Aim: To investigate the protective effect of thymoquinone on smoking-induced vascular damage in 
rats. 
Method: A total of 28 rats were allocated in this experimental study. Rats were equally divided in 
four groups; as control group (n=7) and study groups including only smoking group (n=7), smoking 
plus thymoquinone group (n=7) and smoking plus dexamethasone group (n=7). The animals in study 
groups were subjected to regular cigarette smoke exposure during 2 months, hereby smoking-induced 
vascular injury model was established in the animals. The thoracic aorta of the animals were 
surgically resected and then evaluated histopathologically. The prepared aortic tissue samples were 
analyzed under light microscope in terms of thickness of aortic wall, endothelial continuity and injury 
as well as degenerative alterations on the endothelium. 
Results: Mean aortic wall thicknesses were 77.8 and 114.5 μ in only smoking group and smoking 
plus thymoquinone group respectively, and this difference was statistically significant. In only 
smoking group partial endothelial damage and complete endothelial damage were observed in 2 and 
4 animals respectively whereas in smoking plus thymoquinone group no endothelial damage and 
partial endothelial damage were observed in 2 and 4 animals respectively. When these groups were 
compared in terms of endothelial damage, the difference was detected to be statistically significant.  
Conclusion: Our study demonstrates that thymoquinone has a protective effect on rat endothelium 
and alleviates the smoking-induced vascular damage in rats. 
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Introduction 
Cigarette smoking is one of the most important 
independent risk factors in the development of 
cardiovascular diseases [1]. World Health 
Organization predicts yearly deaths due to 
cigarette smoking will raise to 8 million by 
2030 [2]. It is known that cigarette smoking 
directly contributes the atherogenesis 
especially on endothelial cells. Cigarette 
smoking-induced endothelial dysfunction is 
triggered by the decreased nitric oxide (NO) 
bioavailability and increased expression of 
adhesion molecules. Cigarette smoking-
induced increased adherence of platelets and 
macrophages leads to the occurrence of an 
inflammatory and procoagulant environment 
[1]. In various experimental studies, cigarette 
models in animals has been established, and 
many molecules have been researched to 
alleviate cigarette smoking-induced vascular 
injury in experimental animals. Due to its 
antiinflammatory, antioxidant and 
immunomodulatory properties, thymoquinone 
(2-isopropyl-5-methylbenzo-1,4-quinone) has 
become a intriguing and popular substance for 
the traditional treatment of a wide spectrum of 
diseases especially in Middle East, Northern 
Africa and India [3,4]. Nevertheless, in the 
existing literature the protective or therapeutic 
effect of thymoquinone on cigarette smoking-
induced vascular damage has not been studied 
yet. Therefore, we designed this experimental 
study to determine whether thymoquinone has 
a protective effect against cigarette smoking-
induced vascular damage in rats. 
 
Methods 
 
Experimental animals 
A total of 28 experimental animals were 
obtained from Bolu Abant Izzet Baysal 
University (BAIBU) Experimental Animals 
Research and Practice Center (EARPC). The 
study was conducted experimentally on 2 to 4 
months old male Wistar albino species rats that 
weighed 200-250 grams. Each animal was kept 
under constant temperature (24+/-2 °C) and 
under constant humidity (55+15%) both before 
and during the study at the EARPC. The rats 
were allowed to consume standard rat food and 
water before the study. All experimental 
applications were approved by Animal 
Experiments Local Ethics Committee of 
BAIBU (Decision no: 2019/02/A2). 
 
Establishing smoking-induced vascular 
damage model in animals 
The rats were subjected to cigarette smoke 
inhalation three times a day with 2 cigarettes 
given 15 minutes. This application was 
conducted every day for 2 months. 
 
Study groups 
A control group, a group in which cigarette 
exposure induced vascular damage has 
occurred, another group with vascular damage 
and that received Nigella sativa seed extracts 
and the group consisting of with vascular 
damage and given dexamethasone were the 4 
groups that we had established for our study. 
1. Control group (Group 1, n=7): No procedure 
was performed on the subjects. 
2. Only smoking group (Group 2, n=7): For 
during 2 months every day of each week 3 times 
a day 2 cigarettes were given through a chamber 
with a 15 minutes interval between the 2 
cigarettes thus ensuring the inhalation of the 
cigarette smoke current by the subjects. 
3. Smoking + Thymoquinone group: (Group 3, 
n=7): Rats whom were subjected to cigarette 
smoke inhalation 3 times a day to 2 cigarettes 
15 minutes apart for two months thus inducing 
vascular damage were administered Nigella 
sativa seed extracts via a feeding tube.  
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4. Smoking + Dexamethasone group: (Group 4, 
n=7) : This group was also subjected to same 
cigarette smoke inhalation and endothelial 
damage was established; subjects were given 
50 micrograms/ mL of dexamethasone through 
a feeding tube. 
 
Surgical procedure 
Surgical procedure was performed under 
general anesthesia with intramuscular 10 mg/kg 
ksilazin and 90 mg/kg ketamine. After 
conducting the necessary aseptic practices, for 
exploration of the thoracic aorta a 2 to 3 cm 
vertical incision was performed right beneath 
the cervical part of the rats in the anterior mid-
section. While this incision was done in the 
supine position afterwards the thoracic aorta 
was dissected free from the surrounding tissue 
and resected. Resected thoracic aorta tissue 
samples were kept in 10% formaldehyde 
solution pending histopathological analysis. 
 
Histopathological analysis 
Following the resection the thoracic aorta tissue 
samples were fixed by 10% neutral-buffered 
formalin. The entire aorta was sampled with 3 
mm transvers sections, paraffin embedded and 
sectioned at a 5 μm thickness according to the 
standard procedure. The sections were 
deparaffinized and hydrated gradually, and then 
examined by hematoxylin and eosin staining. 
The dyed slices were analyzed under light 
microscope and were evaluated in terms of 
degenerative alterations such as 
presence/absence of atherosclerosis, 
calcification and fat accumulation as well as 
inflammation, congestion, dilation and fibrosis 
on the endothelium. The slices were also 
evaluated in terms of endothelial continuity and 
damage, as well as thickness of aortic wall. All 
histopathological evaluations were carried out 
by an experienced vascular pathologist. 
Sample size calculation 
Power analysis was used to determine the 
number of the animals in each group. 
According to the power analysis; when 
standard deviation and power were taken as 2 
and 0.80 respectively the n value (number of the 
animals in each group) was found to be 7. Since 
there were 4 groups, the total number of the 
subjects was calculated as 28 animals. 
 
Statistical analysis 
All statistical analyses were performed using 
the Statistical Package for Social Sciences 20.0 
for Windows (SPSS Inc., Chicago, Illinois, 
USA). In order to determine the differences 
among the groups; in comparing the continuous 
variables Kruskal-Wallis test was used while 
for comparing the categorical variables Pearson 
Chi-Square test was employed. When a p value 
was less than 0.05, the differences were 
considered as statistically significant. 
 
Results  
Degenerative alterations on the aortic tissue 
including atherosclerosis, calcification, fat 
accumulation, inflammation, congestion, 
dilation and fibrosis were analyzed in the 
animals, and no any degenerative alterations on 
aortic endothelium were observed in all animals 
in the groups. 
Vascular endothelial continuity and damage 
were analyzed and compared between the 
groups. In control group (Group 1); partial 
endothelial damage was observed in only 1 
animal, and in remaining 6 animals no 
endothelial damage was observed. In only 
smoking group (Group 2); partial endothelial 
damage was observed in 2 animals, and 
complete endothelial damage was observed in 4 
animals. In only 1 animal no endothelial 
damage was observed in Group 2. In smoking 
+ Thymoquinone group (Group 3); no 
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endothelial damage was observed in 2 animals 
while partial endothelial damage was observed 
in 4 animals. In smoking + Dexamethasone 
group (Group 4); no endothelial damage was 
observed in 3 animals while partial endothelial 
damage was observed in 3 animals. In both 
Group 3 and 4, no complete endothelial damage 
was observed. In terms of vascular endothelial 
continuity and damage; when Group 1 and 3 
were compared the difference was not found to 
be statistically significant (p=0.121). When 
Group 1 and 4 were compared in terms of 
endothelial damage, the difference was not 
found to be statistically significant (p=0.273). 
On the other hand, when Group 2 and 3 were 
compared in terms of endothelial damage, the 
difference was found to be statistically 
significant (p=0.014). Similarly, the difference 
was found to be statistically significant when 
Group 2 and 4 were compared (p=0.003). 
Thickness of aortic walls of animals were 
measured and compared between the groups. 
Mean aortic wall thicknesses were 221.2±59.7 
μ in control group (Group 1) and 77.8±29.8 μ in 
only smoking group (Group 2). When Group 1 
and 2 were compared, the difference was found 
to be statistically significant (p=0.001). Mean 
aortic wall thicknesses in smoking + 
Thymoquinone group (Group 3) and smoking + 
Dexamethasone group (Group 4) were 
114.5±21.5 μ and 81.25±13.1 μ, respectively 
(Graphic 1). When Group 3 and 4 were 
compared, the difference was found to be 
statistically significant (p=0.002). In addition, 
when smoking + Thymoquinone group (Group 
3) and only smoking group (Group 2) were 
compared in terms of aortic wall thickness, a 
significantly mean thicker aortic wall was 
observed in Group 3 (smoking + 
Thymoquinone group) (p=0.001). 
Microscopic images related to vascular 
endothelial continuity and damage, and 
thickness of aortic walls of a subject in the 
groups are shown in the Figures 1-4. 
 
 
Graphic 1. Aortic wall thickness in all groups. 
 
Discussion 
The main findings of this experimental study 
were as follows: 1. In animals exposed to only 
smoking (Group 2), thinness on aortic wall was 
observed compared to control group (Group 1). 
2. In animals exposed to smoking along with 
thymoquinone administration (Group 3), 
thickness on aortic wall was observed 
compared to animals exposed to only smoking 
(Group 2). This situation reflects that 
thymoquinone has a protective effect against 
smoking-induced vascular thinness. 3. In 
animals exposed to smoking along with 
thymoquinone administration (Group 3), less 
vascular endothelial damage was observed than 
in animals exposed to only smoking (Group 2). 
This situation reflects that thymoquinone may 
alleviate smoking-induced endothelial damage. 
4. Two-month smoking exposure in rats was no 
significant effect on degenerative alterations on 
aortic endothelium, such as atherosclerosis, 
calcification and fat accumulation. 
Cigarette smoking is known to be a preventable 
risk factor for a variety of clinical conditions 
including cardiovascular diseases. Previous 
studies have established the relationship 
between tobacco consumption and clinical 
entities such as endothelial dysfunction,  
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atherosclerosis and intravascular thrombosis, 
all which have been shown to be important 
etiologic factors in the development of 
hypertension, coronary artery disease and 
myocardial infarction [1]. Individuals who 
consume tobacco have lower combined nitrite, 
nitrate and antioxidant levels in their systemic 
circulation [5]. Tobacco consumption leads to 
the disruption L-arginine–nitric oxide synthase 
(NOS) pathway at the endothelial cellular level 
which in turn causes decreases in NO (nitric 
oxide) production, L-arginine transport and 
expression and activity of NOS [6]. 
Furthermore, exposure to tobacco or cigarette 
smoke inhalation causes the increase of the 
productions of prostaglandin E2 (PGE2), 
cyclooxygenase-2 (COX-2) and intercellular 
adhesion molecule-1 (ICAM-1) and these 
molecular changes establish subclinical 
inflammatory process atherosclerotic condition 
in the body [7]. In addition to the 
aforementioned mechanisms long term 
exposure to cigarette smoke causes the free 
oxygen in the plasma to increase which in turn 
disrupts the oxidant/antioxidant balance which 
all culminates in increased oxidative stress in 
the person. Both imbalanced 
oxidant/antioxidant equilibrium and increased 
oxidative stress affects the NO activation 
adversely leading to the increase of endothelial 
dysfunction and this finally causes the 
intraluminal blood flow to decrease and end-
organ ischemia [8]. In an experimental study in 
mice that were exposed to cigarette smoke for a 
long duration (16 weeks), structural features of 
coronary arteries of mice were affected 
irreversibly and their vascular elasticity had 
been reduced [9]. In another experimental study 
in rats, cigarette smoke exposure was shown to 
cause the contraction of the basilary artery of 
rats and these contractions were significantly 
endothelium-dependent [10]. Drugs and 
chemical agents that we administer to protect 
the health and treat the diseases of humans and 
animals potentially can have adverse effects or 
even more seriously can cause harm hence 
lately alternative and/or supplementary medical 
practices and medications has gained 
momentum and increasing popularity. Among 
them herbal origin products are especially 
widely used [11]. Having very low side effect 
profile and possessing considerable and 
interesting roles as nutrition supplement herbal 
antioxidant usage has become a popular subject 
nowadays. In a recent study by Kaplan et al. 
[12], endothelial dysfunction and inflammation 
that occurs in the thoracic aorta of the mice 
secondarily after being exposed to cigarette 
smoke were attempted to neutralize with alpha 
linolenic acid which is present in flaxseed and 
soy; as a result alpha-linolenic acid was proven 
to inhibit the inflammatory mechanisms and 
prevent the smooth muscle damage caused by 
cigarette smoking. 
Nigella sativa L. that belongs to the 
Ranunculaceae family is a 20-30 cm plant with 
flowers and its habitat comprises Southwest 
Asia, North Africa and Europe. Although 
climate conditions due to different geographic 
regions may cause variations in structure, 
essentially Nigella sativa L. seeds consists of 
fixed and volatile oils, proteins, amino acids, 
carbohydrates, alkaloids, tannins, saponins, 
minerals (calcium, zinc, phosphate) and 
vitamins (ascorbic acid, thiamine, niacin, 
pyridoxine and folic acid). The fixed oil 
contains oleic acid, linoleic acid and 
arachidonic acid as unsaturated fats while 
myristic acid, palmitic acid and stearic acid are 
the saturated fat components. Volatile oils are 
comprised of d-limonene, nigellone, carvacrol, 
α and β-pinene, as well as the main 
pharmacologically active components of 
thymoquinone, dithymoquinone, 
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thymohydroquinone and thymol [13]. Nigella 
sativa L. seeds have been used as a product of 
natural and traditional medicine for centuries 
especially in the Middle East, Northern Africa 
and India and is also being employed for 
headache, fever, flu, coughing, asthma, 
bronchitis, eczema, hypertension, diabetes 
mellitus, obesity, rheumatic diseases and even 
cancers [14]. 
Thymoquinone is the main active phenolic 
hydrophobic substance that is extracted from 
the volatile oil of Nigella sativa L. seeds. 
Studies have shown that thymoquinone through 
different mechanisms has antioxidant, anti-
inflammatory, immunomodulatory, anticancer, 
antimicrobial, hypolipidemic, hypoglycemic, 
antidiabetic effects, and protective effects on 
liver, stomach and kidneys and furthermore it is 
postulated that it can have beneficiary effects 
on cardiac and respiratory diseases. Also the 
studies on the toxic profile of thymoquinone 
have revealed that its toxic effects were seen 
only with very high doses of thymoquinone 
[4,14,15]. As a result with its important 
biological effects and low systemic toxicity the 
clinical importance of thymoquinone is 
increasing, thus it can be a promising 
alternative to the classic therapeutic drugs. 
However, despite these beneficial effects of 
thymoquinone, the molecular mechanisms by 
which these effects are realized have not been 
elucidated yet. 
Considering the potential of antioxidants and 
anti-inflammatory substances’ preventing and 
curing pathologies characterized with 
endothelial damage and dysfunction new 
therapeutic approaches can be devised. In this 
study our goal was to research the effect of 
Nigella sativa seeds’ active component 
thymoquinone’s effect on the endothelial 
damage and changes of the rats that were 
exposed to cigarette smoke. The chosen 
experimental animal is the most genetically and 
physiologically compatible with human beings 
and most suitable species for the study. The 
substances we will use has been reported to be 
as antioxidants in previous studies. Research on 
the preventive effects of these substances on the 
endothelial damage and dysfunction model 
created by cigarette smoke could lead to new 
approaches in the clinical treatments. 
The incidence of cigarette related 
cardiovascular diseases is increasing [1,2]. 
Researches on oxidant/antioxidant balance 
regarding the inflammation which is the 
underlying cause in the etiopathogenesis of 
occlusive vascular diseases has been frequently 
carried out. It has been observed that the main 
goal of the studies is to minimize vascular 
endothelial damage as much as possible and 
curing vascular diseases [16-18]. For this 
purpose, various herbal or chemical compounds 
have been experimented for antioxidant 
therapy. In this present study, we used 
thymoquinone due to its antioxidant and anti-
inflammatory properties, and investigated its 
protective effect on the endothelial damage and 
dysfunction model established with 
experimental cigarette smoke inhalation. Our 
results, whether positive or negative, may be 
used in further studies. The development of 
positive results will enable to reveal new 
approaches in the treatment of oxidative injury 
in occlusive vascular diseases in the clinical 
practice. 
The main limitation of this study was relatively 
small sample size. Another important limitation 
was that not using electron microscopy and 
using only light microscopy. 
 
Conclusions 
To the best of our knowledge, this experimental 
study is the first one investigating the protective 
or therapeutic effect of thymoquinone on 
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cigarette smoking-induced vascular damage. 
The results of our study revealed that 
thymoquinone had a protective effect on the 
vascular endothelium, and alleviated the 
smoking-induced vascular injury in rats. 
Nevertheless, further studies are required to 
achieve high quality evidence. 
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